Barriers to the treatment of hereditary angioedema by self-administration: results of a physician survey

被引:0
|
作者
Boysen, H. B. [1 ]
Bouillet, L. [2 ,3 ]
Neri, S. [4 ]
Hebert, J. [5 ]
Craig, T. [6 ]
Aygoeren-Puersuen, E. [7 ]
Martinez-Saguer, I [8 ]
Bethune, C. [9 ]
机构
[1] HAEi Int Patient Org C1 Inhibitor Deficiencies, Aarhus, Denmark
[2] Grenoble Univ Hosp, Grenoble, France
[3] Natl Reference Ctr Angioedema, Grenoble, France
[4] Univ Catania Policlin, Catania, Italy
[5] Ctr Rech Appl Allergie Quebec, Quebec City, PQ, Canada
[6] Penn State Univ, Hershey, PA USA
[7] Univ Hosp Frankfurt, Frankfurt, Germany
[8] Hamophilie Zentrum Rhein Main, Morfelden Walldorf, Germany
[9] Derriford Hosp, Plymouth PL6 8DH, Devon, England
关键词
D O I
暂无
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:252 / 252
页数:1
相关论文
共 50 条
  • [11] Subcutaneous Icatibant for the Treatment of Hereditary Angioedema Attacks: Comparison of Home Self-Administration with Administration at a Medical Facility
    Otani, Iris M.
    Lumry, William R.
    Hurwitz, Shelley
    Li, Huamin Henry
    Craig, Timothy J.
    Holtzman, Niki S.
    Iandoli, Matthew I.
    Tucker, Julie
    Riedl, Marc A.
    Zuraw, Bruce L.
    Banerji, Aleena
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2017, 5 (02): : 442 - +
  • [12] Subcutaneous Icatibant for the Treatment of Acute Attacks of Hereditary Angioedema: Comparison of Self-Administration to Administration at a Medical Facility
    Otani, Iris
    Lumry, William R.
    Li, Huamin Henry
    Chase, Chevy
    Craig, Timothy J.
    Riedl, Marc A.
    Zuraw, Bruce L.
    Banerji, Aleena
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2016, 137 (02) : AB250 - AB250
  • [13] Self-administration of icatibant in acute attacks of Type I hereditary angioedema: A case report and review of hereditary angioedema
    Piras, Viviana
    Alves, Francisca
    Goncalo, Margarida
    [J]. DERMATOLOGIC THERAPY, 2019, 32 (06)
  • [14] Social costs of icatibant self-administration vs. health professional-administration in the treatment of hereditary angioedema in Spain
    Blasco A.J.
    Lázaro P.
    Caballero T.
    Guilarte M.
    [J]. Health Economics Review, 3 (1) : 1 - 11
  • [15] Self-administration of intravenous C1 esterase inhibitor in hereditary angioedema
    Rizk, Caroline
    Karsh, Jacob
    Santucci, Stephanie
    Yang, William
    [J]. CANADIAN MEDICAL ASSOCIATION JOURNAL, 2013, 185 (09) : 791 - 792
  • [16] Review of Recent Guidelines and Consensus Statements on Hereditary Angioedema Therapy with Focus on Self-Administration
    Cicardi, M.
    Craig, T. J.
    Martinez-Saguer, I.
    Hebert, J.
    Longhurst, H. J.
    [J]. INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2013, 161 : 3 - 9
  • [17] A study of the safety, tolerability and efficacy of self-administration of icatibant for acute attacks of hereditary angioedema
    Aberer, W.
    Wiednig, M.
    Reshef, A.
    Nair, N.
    Lachmann, A.
    Hoch, B.
    Bloom, B.
    Longhurst, H.
    Maurer, M.
    Kivity, S.
    Malbran, A.
    [J]. ALLERGY, 2011, 66 : 80 - 80
  • [18] Self-administration of icatibant to treat hereditary angioedema in four patients with moderate to severe attacks
    Abajian, M.
    Doumoulakis, G.
    Agnieszka, M.
    Schoepke, N.
    Maurer, M.
    Magerl, M.
    [J]. ALLERGY, 2012, 67 : 353 - 353
  • [19] Physician and patient perspectives on the management of hereditary angioedema: a survey on treatment burden and needs
    Riedl, Marc A.
    Craig, Timothy J.
    Banerji, Aleena
    Aggarwal, Kavita
    Best, Jessica M.
    Rosselli, Jinky
    Hahn, Rebecca
    Radojicic, Cristine
    [J]. ALLERGY AND ASTHMA PROCEEDINGS, 2021, 42 : S17 - S25
  • [20] Canadian physician survey on the medical management of hereditary angioedema
    Fu, Lisa
    Kanani, Amin
    Lacuesta, Gina
    Waserman, Susan
    Betschel, Stephen
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2018, 121 (05) : 598 - 603